Related references
Note: Only part of the references are listed.A case report of a patient with refractory adult-onset Still’s disease who was successfully treated with tocilizumab over 6 years
Hideko Nakahara et al.
Modern Rheumatology (2014)
Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome
Masafumi Kobayashi et al.
Modern Rheumatology (2014)
A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
Toru Hirano et al.
Modern Rheumatology (2014)
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis
Takashi Iijima et al.
Modern Rheumatology (2013)
Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases
Yasuaki Okuda et al.
Modern Rheumatology (2013)
Immunotherapeutic implication of IL-6 blockade
Toshio Tanaka et al.
IMMUNOTHERAPY (2012)
Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Role of Interleukin-6 in a Patient With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome Assessment of Outcomes Following Treatment With the Anti-Interleukin-6 Receptor Monoclonal Antibody Tocilizumab
Prashantha M. Vaitla et al.
ARTHRITIS AND RHEUMATISM (2011)
Therapeutic effect of tocilizumab on two patients with polymyositis
Masashi Narazaki et al.
RHEUMATOLOGY (2011)
Treatment of refractory adult-onset still's disease with tocilizumab: report of two cases and review of the literature
Rene Thonhofer et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Mixed response to tocilizumab for ankylosing spondylitis
Joerg C. Henes et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature
Katja Perdan-Pirkmajer et al.
CLINICAL RHEUMATOLOGY (2010)
Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
Daichi Inoue et al.
CLINICAL RHEUMATOLOGY (2010)
Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica
Keisuke Hagihara et al.
JOURNAL OF RHEUMATOLOGY (2010)
Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab
Toshio Tanaka et al.
RHEUMATOLOGY (2010)
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
Yoshihito Shima et al.
RHEUMATOLOGY (2010)
Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment
S. Nishida et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab
Toshio Tanaka et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
Hiroe Sato et al.
CLINICAL RHEUMATOLOGY (2009)
Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis
M. Kawai et al.
RHEUMATOLOGY (2009)
Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
Yasuaki Okuda et al.
ARTHRITIS AND RHEUMATISM (2006)
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
N Nishimoto et al.
BLOOD (2005)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)